ASTS
AST SpaceMobile, Inc.
ASTS has the edge over CNDT overall, supported by stronger fundamentals and stronger modeled upside.
CNDT
Conduent Incorporated
CNDT has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CNDT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
CNDT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CNDT PE Valuation
CNDT has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CNDT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CNDT's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over CNDT on earnings, with more consistent year-over-year improvement.
CNDT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.57 | -$0.66 |
| Q2 2026 | -$1.54 | -1500% |
| Q1 2026 | -$1.04 | -172% |
| Q4 2025 | -$1.14 | -151% |
| Q3 2025 | -$0.91 | -140% |
| Q2 2025 | $0.11 | -45% |
| Q1 2025 | $1.44 | +$2.35 |
| Q4 2024 | $2.23 | +$3.64 |
CNDT is still losing money, but far less than before: $1.57 per share over the past year, against $9.29 at its worst in late 2019.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CNDT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CNDT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $534M | -30% |
| Q2 2026 | $531M | -30% |
| Q1 2026 | $723M | -3.7% |
| Q4 2025 | $770M | -3.7% |
| Q3 2025 | $767M | -5% |
| Q2 2025 | $754M | -8.9% |
| Q1 2025 | $751M | -18% |
| Q4 2024 | $800M | -16% |
CNDT's revenue has slid since its 2019 peak: $534M last quarter, down 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.5% | -1.6 points |
| Q2 2026 | -11% | -5.7 points |
| Q1 2026 | -3.7% | +3.7 points |
| Q4 2025 | -3.6% | +6.6 points |
| Q3 2025 | -5% | -25 points |
| Q2 2025 | -5% | -41 points |
| Q1 2025 | -7.5% | -21 points |
| Q4 2024 | -10% | -9.8 points |
CNDT has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CNDT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$112M | -$58M |
| Q2 2026 | -$2M | +$28M |
| Q1 2026 | -$17M | +$55M |
| Q4 2025 | $24M | -54% |
| Q3 2025 | -$54M | -$33M |
| Q2 2025 | -$30M | +$29M |
| Q1 2025 | -$72M | -$22M |
| Q4 2024 | $52M | -50% |
CNDT has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CNDT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.4x | Net Cash |
| Q2 2026 | -6.5x | Net Cash |
| Q1 2026 | -3.3x | Net Cash |
| Q4 2025 | 13.4x | High |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 0.4x | Very low |
| Q3 2024 | -0.5x | Net Cash |
CNDT has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CNDT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 13.6 | Oversold |
CNDT's weekly RSI is 41 (neutral) and its Stochastic is 14 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CNDT PE vs Technology Sector
| Metric | CNDT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CNDT has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over CNDT on trend strength, trading above more of its moving averages.
CNDT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.53 | 19% below |
| 20 week MA | $1.58 | 22% below |
| 50 week MA | $1.60 | 23% below |
| 100 week MA | $2.23 | 44% below |
| 200 week MA | $2.87 | 57% below |
CNDT is in a downtrend: it's below all five of its weekly moving averages, and 57% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CNDT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.99 | $4.85 | -19% |
| 2021 | $4.85 | $5.36 | +11% |
| 2022 | $5.36 | $4.13 | -23% |
| 2023 | $4.13 | $3.65 | -12% |
| 2024 | $3.65 | $4.08 | +12% |
| 2025 | $4.08 | $1.93 | -53% |
| 2026 YTD | $1.93 | $1.24 | -36% |
CNDT has the edge over ASTS on returns for 2026, with the stronger performance.